Playback speed
10 seconds
EHA 2024 Insights: Golcadomide, an Oral CELMoD, + R-CHOP in Patients With Untreated Aggressive B-Cell Lymphoma
By
Insights from 2024 EHA Annual Meeting
FEATURING
Marc Hoffmann
By
Insights from 2024 EHA Annual Meeting
FEATURING
Marc Hoffmann
30 views
July 18, 2024
Login to view comments.
Click here to Login